Steps to Help Protect Eligible Patients

Number one icon


Identify appropriate patients and discuss the risk of severe RSV based on age and certain underlying conditions

Number two icon


Review the benefits and risks of AREXVY and strongly recommend vaccination for appropriate patients based on their medical history

Number three icon


Address patients’ questions about cost—AREXVY is covered for nearly all patients aged 60 years and older1,2*

Number four icon


Establish a plan that works for your patients to ensure they receive AREXVY at their local pharmacy or in office. If referring to the pharmacy, follow up to make sure they have been vaccinated

*Coverage, coding, cost to patient, reimbursement amount for product, and administration fee will vary by payer, plan (including whether your patient is covered by Medicare or commercial insurance), patient, professional setting, or services rendered, and are subject to change without notice. Cost to patients may vary. Coverage and reimbursement decisions are made by individual insurance plans following receipt of claims from providers. Providers must follow documentation and billing requirements of payer.

Flagship icon

#1 in RSV vaccine doses administered to adults 60 years and older.3†

Over 7 million adults 60 years and older vaccinated against RSV-LRTD with AREXVY as of March 2024.3‡

Retail claims July 2023-March 2024; retail making up majority of RSV market.

Based on data of total retail pharmacy prescriptions in the US from July 2023 through March 2024, showing 7.07 million prescriptions for AREXVY.

RSV season isn't over icon

Vaccinating with AREXVY is a conversation worth having

It's important to start the conversation now about AREXVY with your appropriate unvaccinated patients.

  • Review RSV and its potential risks
  • Discuss the option of vaccination today

Patient Counseling Information

Male AREXVY patient
Male AREXVY patient
  • Inform vaccine recipients of the potential benefits and risks of vaccination with AREXVY
  • Inform vaccine recipients about the potential for adverse reactions that have been observed following administration of AREXVY
  • Provide the Vaccine Information Statements, which are available free of charge on the CDC website


Downloadable Guides

For pharmacy personnel